Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE A Benefit-Risk Analysis of EINSTEIN-Extension

Philip S. Wells, Martin H. Prins, Bennett Levitan, Jan Beyer-Westendorf, Timothy A. Brighton, Henri Bounameaux, Alexander T. Cohen, Bruce L. Davidson, Paolo Prandoni, Gary E. Raskob, Zhong Yuan, Eva G. Katz, Martin Gebel, Anthonie W. A. Lensing

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)1059-1068
JournalChest
Volume150
Issue number5
DOIs
Publication statusPublished - Nov 2016

Keywords

  • anticoagulation
  • benefit-risk
  • rivaroxaban
  • VTE

Cite this

Wells, P. S., Prins, M. H., Levitan, B., Beyer-Westendorf, J., Brighton, T. A., Bounameaux, H., Cohen, A. T., Davidson, B. L., Prandoni, P., Raskob, G. E., Yuan, Z., Katz, E. G., Gebel, M., & Lensing, A. W. A. (2016). Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE A Benefit-Risk Analysis of EINSTEIN-Extension. Chest, 150(5), 1059-1068. https://doi.org/10.1016/j.chest.2016.05.023